A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori
Open Access
- 1 November 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Gastroenterology
- Vol. 106 (11), 1970-1975
- https://doi.org/10.1038/ajg.2011.306
Abstract
OBJECTIVES: METHODS: RESULTS: CONCLUSIONS:This publication has 40 references indexed in Scilit:
- Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori InfectionClinical Gastroenterology and Hepatology, 2010
- Efficacy of a New Therapeutic Regimen Versus Two Routinely Prescribed Treatments for Eradication of Helicobacter Pylori: A Randomized, Double-Blind Study of Doxycycline, Co-Amoxiclav, and Omeprazole in Iranian PatientsDigestive Diseases and Sciences, 2008
- New concepts of resistance in the treatment of Helicobacter pylori infectionsNature Clinical Practice Gastroenterology & Hepatology, 2008
- Helicobacter pylori Recurrence in Developed and Developing Countries: Meta‐Analysis of 13C‐Urea Breath Test Follow‐Up after EradicationHelicobacter, 2008
- American College of Gastroenterology Guideline on the Management of Helicobacter pylori InfectionThe American Journal of Gastroenterology, 2007
- A Report Card to Grade Helicobacter pylori TherapyHelicobacter, 2007
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut, 2007
- Systematic review and meta‐analysis: levofloxacin‐based rescue regimens after Helicobacter pylori treatment failureAlimentary Pharmacology & Therapeutics, 2005
- In Vitro Antibacterial Potency and Spectrum of ABT-492, a New FluoroquinoloneAntimicrobial Agents and Chemotherapy, 2003
- Nitazoxanide, a Nitrothiazolide Antiparasitic Drug, Is an Anti-Helicobacter pylori Agent with Anti-Vacuolating Toxin ActivityChemotherapy, 1999